Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing weight on Wegovy works best when the medicine is one part of a deliberate plan, not the whole plan. Semaglutide reduces appetite significantly, but the patients who see the most sustained results are typically the ones who use that reduced hunger as an opening — eating well, moving more, and sleeping consistently — rather than waiting for the medicine to do everything. Wegovy is a prescription-only medicine; a clinician assesses whether it is right for you before it can be prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, some version of "do I really need to change what I eat if I'm already on Wegovy?" It is understandable. The appetite suppression is real, sometimes dramatic, and it can feel as though the medicine has already solved the problem. But the clinical evidence tells a different story.
In the STEP 1 trial, participants on semaglutide 2.4mg who combined treatment with a reduced-calorie diet and increased activity achieved around 15% average body-weight reduction over 68 weeks, results that assumed lifestyle changes were happening alongside the medicine, not instead of them. The NHS semaglutide medicines page describes weight management with semaglutide explicitly in the context of a reduced-calorie diet and increased physical activity. Wegovy is licensed on exactly that basis.
The practical implication: think of the reduced appetite as a window of opportunity. You will feel fuller on less food. Use that to build the habits (regular meals, adequate protein, consistent movement) that persist after treatment ends. The medicine lowers the effort required to eat less; it does not remove the need to eat well.
For a broader look at what the evidence says about losing weight on Wegovy, including realistic timelines, there is more detail on that topic separately.
Wegovy slows gastric emptying as well as reducing appetite, which means very rich or fatty meals can sit heavily and trigger nausea. Most people find that smaller portions, eaten slowly, feel far more comfortable than they did before treatment, and that is not a coincidence, it is part of how the medicine works.
Protein is worth prioritising. When the body is in a calorie deficit, muscle can be lost alongside fat; adequate protein (alongside any resistance exercise you can manage) reduces that loss. Aim for protein at most meals: eggs, fish, lean meat, legumes, dairy. It also tends to sustain satiety longer than refined carbohydrates, which matters on a medicine that is already working on hunger signals.
Fibre-rich vegetables, wholegrains and pulses support digestive regularity, which is helpful given that constipation is a commonly reported side effect. Keep fluid intake up throughout the day, dehydration amplifies nausea and fatigue, two of the most frequently reported early experiences on GLP-1 treatment.
Alcohol is worth reconsidering. It is calorie-dense, disrupts sleep quality, and can intensify nausea on semaglutide for some people. You do not have to stop entirely, but many people find their tolerance shifts noticeably during treatment. If you want practical guidance on using Wegovy day to day, including injection technique and timing, that covers the operational side of treatment.
You do not need to join a gym or run five kilometres. The evidence consistently shows that any regular increase in physical activity supports better outcomes during weight-loss treatment, and that resistance exercise in particular (bodyweight work, resistance bands, weights) helps protect lean muscle mass.
Start with what you will actually do. A 20-minute walk most days is a genuinely good starting point. NHS England's guidance on weight-management medicines recommends increasing physical activity as part of treatment, not as an optional extra. As energy levels stabilise (which typically happens once the initial GI adjustment period has passed) building in two or three sessions of resistance work per week is worth considering, and our Wegovy weight loss tips go into more detail on how to structure that alongside treatment.
Sleep is part of this too. Poor sleep raises hunger hormones and makes the appetite-regulating effects of semaglutide harder to maintain. Seven to nine hours of consistent sleep is not a luxury; it is a factor that affects how well almost every weight-management intervention works.
For context on how semaglutide supports weight loss at a mechanistic level, there is more on the science behind GLP-1 receptor activation on that page.
Nausea, loose stools or constipation, and fatigue are most common in the first few weeks of treatment and after each dose step up. They are not a sign that something is wrong; they are a predictable consequence of the medicine's mechanism. Most people find them manageable with a few adjustments: eating smaller meals, avoiding high-fat or heavily spiced foods, keeping a bottle of water nearby, and not rushing upright immediately after eating, and our Wegovy tips cover these practical adjustments in more depth if you want a fuller reference.
Slow weeks (when the scale does not move despite doing everything right) are genuinely normal. Weight loss on semaglutide is not linear. Hormonal fluctuations, fluid retention, and muscle gain from exercise can all mask fat loss temporarily. The direction of travel over four to six weeks is more meaningful than any single weigh-in.
If side effects are severe or persistent, speak to your prescriber. The NHS guidance on semaglutide sets out which symptoms warrant prompt medical attention, including severe stomach pain that radiates to the back, a symptom to take seriously and seek help for promptly. Any suspected side effects can be reported to the MHRA via the Yellow Card scheme.
If you are weighing up the cost of private treatment, it is worth reading about Wegovy pricing in the UK to understand what goes into a legitimate prescription and what the market looks like honestly. When you are ready to see whether treatment is appropriate for you, check your eligibility with our clinical team, a GPhC-registered prescriber, not an algorithm, reviews every consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.